NO306195B1 - Use of <alfa> ketoglutarate - Google Patents

Use of <alfa> ketoglutarate

Info

Publication number
NO306195B1
NO306195B1 NO940190A NO940190A NO306195B1 NO 306195 B1 NO306195 B1 NO 306195B1 NO 940190 A NO940190 A NO 940190A NO 940190 A NO940190 A NO 940190A NO 306195 B1 NO306195 B1 NO 306195B1
Authority
NO
Norway
Prior art keywords
ketoglutarate
alfa
Prior art date
Application number
NO940190A
Other languages
Norwegian (no)
Other versions
NO940190L (en
NO940190D0 (en
Inventor
Erik Vinnars
Jan Wernerman
Original Assignee
Vinnars Erik Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vinnars Erik Ab filed Critical Vinnars Erik Ab
Publication of NO940190L publication Critical patent/NO940190L/en
Publication of NO940190D0 publication Critical patent/NO940190D0/en
Publication of NO306195B1 publication Critical patent/NO306195B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
NO940190A 1992-05-20 1994-01-19 Use of <alfa> ketoglutarate NO306195B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9201584A SE9201584D0 (en) 1992-05-20 1992-05-20 USE OF ALPHA KETOGLUTARATE
PCT/SE1993/000426 WO1993023027A1 (en) 1992-05-20 1993-05-14 Use of alpha-ketoglutarate

Publications (3)

Publication Number Publication Date
NO940190L NO940190L (en) 1994-01-19
NO940190D0 NO940190D0 (en) 1994-01-19
NO306195B1 true NO306195B1 (en) 1999-10-04

Family

ID=20386290

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940190A NO306195B1 (en) 1992-05-20 1994-01-19 Use of <alfa> ketoglutarate

Country Status (7)

Country Link
EP (1) EP0612245A1 (en)
JP (1) JPH06509362A (en)
AU (1) AU661399B2 (en)
CA (1) CA2113279A1 (en)
NO (1) NO306195B1 (en)
SE (1) SE9201584D0 (en)
WO (1) WO1993023027A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9303691D0 (en) * 1993-11-09 1993-11-09 Gramineer Ab New beverage
SE9402027D0 (en) * 1994-06-10 1994-06-10 Pharmacia Ab Energy substrates
US20050085498A1 (en) * 1998-05-28 2005-04-21 Byrd Edward A. Oral formulation of lipid soluble thiamine, lipoic acid, creatine derivative, and L-arginine alpha-ketoglutarate
US20020147237A1 (en) * 2001-01-31 2002-10-10 Lars Wiklund Preservation of bodily protein
MXPA02010149A (en) * 2001-02-14 2004-08-19 Matthias Rath Compositions of biochemical compounds involved in bioenergy metabolism of cells.
SE0301947D0 (en) * 2003-07-01 2003-07-01 Gramineer Internat Ab New method and uses
CA2628265A1 (en) * 2005-11-08 2007-05-18 Multi Formulations Ltd. The use of compositions comprising ketoacids and amino acids for increasing muscle mass and muscle performance
WO2012143405A1 (en) * 2011-04-18 2012-10-26 Nestec S.A. Nutritional compositions having alpha-hica and alpha-ketoglutarate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987003806A1 (en) * 1985-12-18 1987-07-02 Veech Richard L Parenteral nutrition therapy with amino acids
SE8704217D0 (en) * 1987-10-29 1987-10-29 Vinnars Erik Ab AMINO ACID COMPOSITION FOR PARENTERAL NUTRITION

Also Published As

Publication number Publication date
AU4098993A (en) 1993-12-13
WO1993023027A1 (en) 1993-11-25
NO940190L (en) 1994-01-19
NO940190D0 (en) 1994-01-19
JPH06509362A (en) 1994-10-20
SE9201584D0 (en) 1992-05-20
AU661399B2 (en) 1995-07-20
EP0612245A1 (en) 1994-08-31
CA2113279A1 (en) 1993-11-25

Similar Documents

Publication Publication Date Title
FI944885A (en) The basic part of the can
FI946086A0 (en) Manufacture of basic metals
NO307425B1 (en) Corrosion
KR950700875A (en) PREPARATION OF SUBSTITUTED GUANIDINES
FI945085A0 (en) A combination of neu-reseptoristimulaatiotekijä
IS4180A (en) Use of indenoindole compounds
NO306195B1 (en) Use of &lt;alfa&gt; ketoglutarate
DE69324812T2 (en) CELL ACTIVATOR OF THE INTEGRAL TRACT
FI935702A0 (en) Conversion of ferrous metal sulphide
ITPD920013V0 (en) STRAP OF STRAP
FI954422A (en) Use of ferrous metal
NO931399D0 (en) USE OF NATURSTEIN
NO952949D0 (en) Precursors of anti-inflammatory 3-acyl-2-oxindole-1-carboxamides
FI950082A0 (en) Length-stabilized vessel of displacement type
ITMI912654A1 (en) COMBINATION OF EXTRUDER-CALENDER
FI951212A (en) manufacture of beta-methylcarbapenem intermediates
BR9202577A (en) EMPLOYMENT OF SOLUTIONS
FI940309A (en) Lysine salt of 6-chloro-5-fluoro-3- (2-tenoyl) -2-oxindole-1-carboxamide
NO944839D0 (en) Use of bismuth
BR9305739A (en) Manufacture of elongated superconductors
KR930026760U (en) Improved configuration of TVCR
LV10073A (en) Influence of Absinthis absolutizesan
KR950013629U (en) De-energizer of De-energizer
LT2564B (en) BUDS ISSKIRIT SOMATOTROPINA IS ZMOGAUS HIPOFIZIU
FI930479A0 (en) EXTENSION OF MEASUREMENT

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN NOVEMBER 2002